BIOMERICA INC. - COMMON STOCK
0,3401
03-января-25 15:45:00
15 мин. задержка
Акции
+0,0371
+12,24%
Сегодняшний диапазон
0,2900 - 0,3411
ISIN
N/A
Источник
NASDAQ
- Котировки
- Графики
Новости
- Статистика
-
26 сен 2023 07:19:00 Источник Nasdaq GlobeNewswire
-
Diagnostics Industry Leader Jack Kenny Joins Biomerica’s Board of Directors
28 авг 2023 07:19:00 Источник Nasdaq GlobeNewswire
-
Biomerica Reports Fiscal 2023 Year End Results
25 авг 2023 16:00:00 Источник Nasdaq GlobeNewswire
-
03 авг 2023 07:19:00 Источник Nasdaq GlobeNewswire
-
inFoods® IBS Test Now Validated for Use with Simple Finger Stick Whole Blood Collection Technology
18 май 2023 07:19:00 Источник Nasdaq GlobeNewswire
-
17 апр 2023 06:47:00 Источник Nasdaq GlobeNewswire
-
Biomerica Reports Q3 Fiscal 2023 Results
14 апр 2023 15:48:29 Источник Nasdaq GlobeNewswire
-
08 мар 2023 07:19:00 Источник Nasdaq GlobeNewswire
-
Biomerica Announces Closing of $8 Million Underwritten Public Offering of Common Stock
07 мар 2023 15:39:57 Источник Nasdaq GlobeNewswire
-
Biomerica Announces Pricing of $8 Million Underwritten Public Offering of Common Stock
03 мар 2023 06:30:00 Источник Nasdaq GlobeNewswire
-
Biomerica Announces Proposed Underwritten Public Offering of Common Stock
02 мар 2023 16:15:01 Источник Nasdaq GlobeNewswire
-
Biomerica Reports Financial Results for Fiscal 2023 Second Quarter Ended November 30, 2022
13 янв 2023 17:39:00 Источник Nasdaq GlobeNewswire
-
10 янв 2023 07:19:00 Источник Nasdaq GlobeNewswire
-
08 дек 2022 07:19:00 Источник Nasdaq GlobeNewswire
-
02 ноя 2022 07:19:00 Источник Nasdaq GlobeNewswire
-
14 окт 2022 08:18:00 Источник Nasdaq GlobeNewswire
-
Biomerica Reports 30% Increase in Revenues for Fiscal Q1 2023 vs. Fiscal Q1 2022
13 окт 2022 15:50:00 Источник Nasdaq GlobeNewswire
-
29 сен 2022 07:19:00 Источник Nasdaq GlobeNewswire
-
Biomerica Plans Launch of InFoods® IBS Test; Names Robert Carlson as Chief Commercial Officer
30 авг 2022 07:19:00 Источник Nasdaq GlobeNewswire